‘Selling and marketing snake oil’: The debate over compounded GLP-1s
Proponents of compounding argue it increases access, lowers prices and helps patients who may need individualized versions of a drug. But there are serious concerns, experts said at the HLTH conference.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- ‘Selling and marketing snake oil’: The debate over compounded GLP-1s healthcaredive.com